FDA inspectors cited 14 sterility and manufacturing concerns at Houston RX, the maker of recalled compounded tirzepatide. What GLP-1 users should check.
Houston Pharmacy Behind Recalled Compounded Tirzepatide Vials Drew 14 FDA Inspection Observations, Including Exposed Skin and Research-Grade Ingredients
by | Oct 19, 2026 | Uncategorized | 0 comments
Recent Comments